Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer.
about
Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone.Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients.A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer.Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 'real-life' studies
P2860
Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Predictors of duration of abir ...... ion-resistant prostate cancer.
@en
Predictors of duration of abir ...... ion-resistant prostate cancer.
@nl
type
label
Predictors of duration of abir ...... ion-resistant prostate cancer.
@en
Predictors of duration of abir ...... ion-resistant prostate cancer.
@nl
prefLabel
Predictors of duration of abir ...... ion-resistant prostate cancer.
@en
Predictors of duration of abir ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P356
P1476
Predictors of duration of abir ...... ion-resistant prostate cancer.
@en
P2093
M Fiorillo
M Nakabayashi
M-E Taplin
P2860
P2888
P304
P356
10.1038/PCAN.2016.31
P577
2016-08-09T00:00:00Z
P6179
1009295271